Wei Deng

3PUBLICATIONS
3CO-AUTHORS
Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 25, 2025
The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma.

Wei Deng, Jin Xie, Tao Wang

|Jul 09, 2024
Prognostic Value of Alpha-Fetoprotein in Unresectable Hepatocellular Carcinoma Treated with Hepatic Artery Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab.

Yongqiang Xiao, Wanqing Chen, Wei Deng

|Nov 15, 2023
Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab.

Yongqiang Xiao, Guoqing Zhu, Jin Xie

Pageof 1

Frequent Collaborators

3 joint publications

Yongqiang Xiao

3 joint publications

Laihui Luo

1 joint publications

Renfeng Shan